Tissue expression
Cell line expression

NAT2

gene product
AAC2 
This gene encodes an enzyme that functions to both activate and deactivate arylamine and hydrazine drugs and carcinogens. Polymorphisms in this gene are responsible for the N-acetylation polymorphism in which human populations segregate into rapid, intermediate, and slow acetylator phenotypes. Polymorphisms in this gene are also associated with higher incidences of cancer and drug toxicity. A second polymorphic arylamine N-acetyltransferase gene (NAT1), is located near this gene (NAT2). [provided by RefSeq, Sep 2019]
More gene data

Antibodies

 

Filters

Application

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Antigen sequence

Conjugate

Epitope

Antibody

  or   Clear
Enhanced validation
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
260 antibodies from 27 providers.

Antibody properties

Applications

or Cancel
AntibodyRefsTypeWBELICCIPIHCFC
antibodies-online
127 antibodies
Biorbyt
18 antibodies
Aviva Systems Biology
5 antibodies
Cusabio Biotech Co., Ltd
5 antibodies
Abgent
3 antibodies
LifeSpan BioSciences, Inc.
33 antibodies
Invitrogen Antibodies
6 antibodies
ProSci
3 antibodies
Boster Biological Technology
1 antibody
Wuhan Fine Biotech Co., Ltd.
1 antibody
Novus Biologicals
7 antibodies
OriGene
5 antibodies
Abnova Corporation
5 antibodies
GeneTex
2 antibodies
RabMAbs
1 antibody
Signalway Antibody LLC
1 antibody
MyBioSource
4 antibodies
Acris Antibodies GmbH
2 antibodies
Creative Diagnostics
2 antibodies
Abbexa
6 antibodies
NovoPro Bioscience Inc.
1 antibody
Proteintech Group
1 antibody
United States Biological
13 antibodies
Leading Biology
2 antibodies
MilliporeSigma / Merck KGaA
2 antibodies
Everest Biotech
1 antibody
Creative Biolabs
3 antibodies